Biotech News | The Chronicus Post

Icahn, Whitworth Boosted Stakes in Drugmaker Genzyme During Fourth Quarter

Activist investors Carl Icahn and Ralph Whitworth raised their stakes in Genzyme...

Charles River suspending Shrewsbury operations

Charles River Laboratories International Inc., which conducts research for drug developers, will suspend operations at its Shrewsbury facility and lay off 300 workers by mid-2010 because of weak demand for the company's preclinical services, Charles River reported...

READ THE FULL ARTICLE >>

For Kids, All Activity May Not Be Equal

It sounds simple enough: Kids need to be active. When they are, they're less likely to be overweight and prone to the health risks that accompany extra...

READ THE FULL ARTICLE >>

Good News for Vical Cancer Drug Candidate

Vical Inc. announced recently that its cancer drug candidate Allovectin-7 has received a positive opinion from an independent safety review...

READ THE FULL ARTICLE >>

Santarus Submits Ind for Phase III Clinical Testing of Rifamycin SV MMX in Travelers’ Diarrhea

Santarus, Inc. , a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX in patients with travelers'...

READ THE FULL ARTICLE >>

Ranbaxy exits Chinese JV

The joint venture between the Ranbaxy group; Guangzhou Baiyunshan Pharmaceutical Company Ltd, China, and Hong Kong New ChemicRanbaxy was formed in...

READ THE FULL ARTICLE >>

Teva advances

Teva Pharmaceutical Industries has tired of waiting for the U.S. government to establish a pathway for approval of generic versions of biologic...

READ THE FULL ARTICLE >>

Cell Therapeutics, Inc. Adopts Shareholder Rights Plan

Cell Therapeutics, Inc. announced today that on December 24, 2009, CTI's Board of Directors approved and adopted a Shareholder Rights Plan in which one preferred stock purchase right will be distributed for each common share held as of the close of business on January 7,...

READ THE FULL ARTICLE >>